原料药与母体药物
Naratriptan
CAS 121679-13-8 · C17H25N3O2S · 25 杂质与相关化合物
01原料药与母体药物
二维结构PubChem CID 4440

| CAS RN | 121679-13-8 |
|---|---|
| PubChem CID | 4440 |
| 分子式 | C17H25N3O2S |
| IUPAC 名称 | N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide |
| 已定义立体中心 | 0 |
| 未指定立体中心 | 0 |
02亚硝胺结构筛查
该结果不能证明形成风险或不存在风险。需要针对具体工艺进行评估。
03印度监管状态
仅将精确化合物与公布的标识符进行比较。作出监管决定前请核对现行官方文件。
05来源
- S01

![二维结构: (1E)-N-Methyl-2-[1-(phenylmethyl)-1H-indol-5-yl]ethenesulfonamide, CAS 894351-84-9](/structures/pubchem/29983966/894351-84-9-1e-n-methyl-2-1-phenylmethyl-1h-indol-5-yl-ethenesulfonamide-2d-structure-300.png)





![二维结构: Bisaryl naratriptan / 2,2-Bis-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonic Acid Methylamide, CAS 1346604-16-7](/structures/pubchem/71314099/1346604-16-7-bisaryl-naratriptan-2-2-bis-3-1-methylpiperidin-4-yl-1h-indol-5-yl-ethanesulfonic-acid-met-2d-structure-300.png)








![二维结构: N-Sulfamoylethyl naratriptan pyridinium / 4-[1,5-Bis-(2-Methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium chloride, CAS 2144776-33-8](/structures/pubchem/71314089/2144776-33-8-n-sulfamoylethyl-naratriptan-pyridinium-4-1-5-bis-2-methylsulfamoylethyl-1h-indol-3-yl-1-m-2d-structure-300.png)








